MDxHealth SA ADR (MDXH)

Currency in USD
0.1063
-0.0111(-9.45%)
Real-time Data·
Trading near 52-week Low
MDXH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.10120.1181
52 wk Range
0.10124.3400
Key Statistics
Prev. Close
0.1174
Open
0.11
Day's Range
0.1012-0.1181
52 wk Range
0.1012-4.34
Volume
826.47K
Average Volume (3m)
918.64K
1-Year Change
-96.7692%
Book Value / Share
-0.26
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDXH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.8333
Upside
+683.94%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

MDxHealth SA ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
5 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.8333
(+683.94% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Hold---MaintainNov 13, 2026
BTIG
Hold---DowngradeOct 19, 2026
Lake Street
Hold0.50+376.19%-DowngradeOct 16, 2026
Craig-Hallum
Hold---DowngradeOct 16, 2026
BTIG
Buy2.00+1,804.76%4.00MaintainAug 21, 2026

MDxHealth SA ADR Earnings Call Summary for Q3/2026

  • MDxHealth Q3 revenue of $22.7M missed consensus by 21%, falling to $28.75M forecast amid sales-force turnover and commercial disruption.
  • Gross margin compressed 320bps to 61.8% as product mix shifted toward lower-margin liquid testing; operating loss widened to $8.1M from $4.4M.
  • Management called Q3 the 'low point,' expects Q4 flat sequentially with recovery beginning 2027 as new sales reps ramp over 1-2 quarters.
  • Company restructuring sales organization after accelerated turnover from Resolve UTI wind-down; aims for full staffing by end of Q4 2026.
  • Shares fell 4.44% to $0.14 but rebounded 6.79% after-hours; cash at $31.7M raises concerns about burn rate amid widening losses.
Last Updated: 2026-11-12, 05:14 p/m
Read Full Transcript

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-0.16 / -0.09
Revenue / Forecast
22.71M / 28.75M
EPS Revisions
Last 90 days

MDXH Income Statement

Compare MDXH to Peers and Sector

Metrics to compare
MDXH
Peers
Sector
Relationship
P/E Ratio
−0.3x−3.2x−0.2x
PEG Ratio
0.011.010.00
Price/Book
−0.5x−34.4x2.6x
Price / LTM Sales
0.1x15.4x2.7x
Upside (Analyst Target)
-39.4%72.2%
Fair Value Upside
Unlock−4.4%12.4%Unlock

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company’s testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient’s previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient’s infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
674.96K0.71%94.56K
Other Institutional Investors
59.23M62.08%8.30M
Public Companies & Retail Investors
35.51M37.21%4.97M
Total
95.42M100.00%13.37M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bleichroeder LP32.04%30,571,9224,283
Lytton-Kambara Foundation12.14%11,583,0981,623

People Also Watch

0.911
AARD
-8.90%
0.0030
SHFS
+15.38%
7.625
TKNO
-2.37%

FAQ

What Is the MDxHealth ADR (MDXH) Stock Price Today?

The MDxHealth ADR stock price today is 0.1063 USD.

What Stock Exchange Does MDxHealth ADR Trade On?

MDxHealth ADR is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for MDxHealth ADR?

The stock symbol for MDxHealth ADR is "MDXH."

What Is the MDxHealth ADR Market Cap?

As of today, MDxHealth ADR market cap is 11.2000M USD.

What Is MDxHealth ADR's Earnings Per Share (TTM)?

The MDxHealth ADR EPS (TTM) is -0.68.

When Is the Next MDxHealth ADR Earnings Date?

MDxHealth ADR will release its next earnings report on Mar 03, 2027.

From a Technical Analysis Perspective, Is MDXH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has MDxHealth ADR Stock Split?

MDxHealth ADR has split 1 times.

How Many Employees Does MDxHealth ADR Have?

MDxHealth ADR has 364 employees.

What is the current trading status of MDxHealth ADR (MDXH)?

As of Nov 20, 2026, MDxHealth ADR (MDXH) is trading at a price of 0.1063 USD, with a previous close of 0.1174 USD. The stock has fluctuated within a day range of 0.1012 USD to 0.1181 USD, while its 52-week range spans from 0.1012 USD to 4.3400 USD.

What Is MDxHealth ADR (MDXH) Price Target According to Analysts?

The average 12-month price target for MDxHealth ADR is 0.8333 USD, with a high estimate of 1 USD and a low estimate of 0.5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +683.94% Upside potential.

What Is the MDXH Premarket Price?

MDXH's last pre-market stock price is 0.1110 USD. The pre-market share volume is 6,770.0000, and the stock has decreased by -0.0064, or -5.4500%.

What Is the MDXH After Hours Price?

MDXH's last after hours stock price is 0.1276 USD, the stock has decreased by 0.0102, or 8.6900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.